Delivery Order SPE2DR25D1201-SPE2DR26FAKJD
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 30, 2025, by the Defense Logistics Agency (DLA) for the supply of Jardiance 10 mg tablets in quantities of 90 units. This firm fixed-price delivery order, valued at $32,598.70, is scheduled for completion by October 31, 2025, and represents a non-set-aside competitive award. The contract will be performed at the contractor's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,732.24 on January 7, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). The contract is a firm fixed-price delivery order with no set-aside designation, awarded by the Defense Logistics Agency (DLA), the Department of Defense's supply chain management organization responsible for medical procurement. Performance will be completed...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on December 22, 2025, by the Defense Logistics Agency for the supply of Jardiance 10 mg tablets (90-count packages). This non-set-aside, competitively awarded delivery order carries a firm fixed price ceiling value of $23,196.13 and is scheduled for ultimate completion on December 23, 2025. The award represents a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 6, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $11,878.85. This competitive, firm fixed-price delivery order is set to be completed by November 7, 2025, and represents a single-line procurement under AmerisourceBergen's larger pharmaceutical supply framework with the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,464.31 on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages). This non-set-aside, competitively awarded contract with firm fixed pricing is funded by the Defense Logistics Agency (DLA) and is scheduled for completion by January 7, 2026. The award represents a task order issued under AmerisourceBergen's parent company,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 26, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $19,092.10. This non-set-aside, competitively awarded delivery order is scheduled for completion by December 29, 2025, and represents a routine pharmaceutical procurement supporting federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 20, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This is a firm fixed price delivery order with a ceiling value of $27,568.39 and an ultimate completion date of November 21, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 12, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, non-set-aside delivery order carries a ceiling value of $11,849.86 and is scheduled for completion by November 13, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,094.36 by the Defense Logistics Agency for the supply of Jardiance 25 mg tablets (90-count packages). The contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $30,051.78 by the Defense Logistics Agency on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKJDDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 6, 2026, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $45,388.56. This firm fixed-price, competitively awarded contract involves no set-aside designation and is scheduled for completion by January 7, 2026. The contract is performed at the awardee's location in Conshohocken, Pennsylvania, and is funded by the Defense Logistics Agency (DLA), which operates under the Department of Defense. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. Jardiance, a diabetes medication, is consistent with AmerisourceBergen's established portfolio of delivering therapeutic medications across multiple disease categories to federal military and healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.4k | 1/5/26 |